About Biomaneo
Biomaneo is a company based in Dijon (France) founded in 2016 by Patrick Ducoroy and Valerie GEOFFROY was acquired by Shimadzu Corporation in May 2023. Biomaneo offers products and services including Chemistry and Diagnostics Products. Biomaneo operates in a competitive market with competitors including Sanguina, DiaSpect, Blaze Medical Devices, Clinical Diagnostic Solutions and Aviv Biomedical, among others.
- Headquarter Dijon, France
- Founders Patrick Ducoroy, Valerie GEOFFROY
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Shimadzu Corporation
(May 31, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomaneo
Biomaneo offers a comprehensive portfolio of products and services, including Chemistry and Diagnostics Products.
Products for chemistry and diagnostics applications in healthcare.
Funding Insights of Biomaneo
Detailed funding history for Biomaneo
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biomaneo
Biomaneo has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Shimadzu Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical imaging systems, industrial machinery, and analytical instruments are provided.
|
Locked | Locked | Locked |
Investor details for Biomaneo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomaneo
Investment portfolio details for Biomaneo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biomaneo
Detailed financials for Biomaneo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomaneo Comparisons
Peer comparison for Biomaneo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomaneo
Biomaneo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanguina, DiaSpect, Blaze Medical Devices, Clinical Diagnostic Solutions and Aviv Biomedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
POC anemia test is conducted using a single blood droplet.
|
|
| Locked | Locked | Locked |
Handheld hemoglobin analyzers for reagent-free whole blood testing are developed.
|
|
| Locked | Locked | Locked |
Testing of blood damage and health of RBC
|
|
| Locked | Locked | Locked |
Offers hematology analyzers, reagents, and services for physician offices and small hospitals.
|
|
| Locked | Locked | Locked |
Aviv Biomedical offers a portfolio of spectrometers and fluorometers.
|
Detailed competitors of Biomaneo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomaneo
Complete news archive for Biomaneo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomaneo
Biomaneo was founded in 2016.
Biomaneo is headquartered in Dijon, France. It is registered at Dijon, Bourgogne-franche-comte, France.
Patrick Ducoroy is the current CEO of Biomaneo. They have also founded this company.
Biomaneo was founded in 2016 in Dijon, France, within the biotechnology sector. Medical test kits for neonatal screening are developed, with the flagship product focusing on sickle cell disease detection through protein analysis of dried blood samples via mass spectrometry. Integration with laboratory information management systems is enabled via the NeoScreening solution for data management, traceability, and analysis. Operations are centered on healthcare diagnostics.
Biomaneo's top competitors include Sanguina, DiaSpect and Blaze Medical Devices.
Biomaneo offers Chemistry and Diagnostics Products.
Biomaneo has 1 investor. Key investors include Shimadzu Corporation.